Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
JHEP Reports : Innovation in Hepatology|October 7, 2020
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCCVicki Wing-Ki Hui, Stephen Lam Chan, Vincent Wai-Sun Wong, et al.Alimentary Pharmacology & Therapeutics|July 29, 2023
Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infectionGrace Chung-Yan Lui, Vicki Wing-Ki Hui, Shun-Fung Sze, et al.Cancers|May 13, 2023
Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular CarcinomaClaudia Wing-Kwan Wu, Rashid Nok-Shun Lui, Vincent Wai-Sun Wong, et al.Alimentary Pharmacology & Therapeutics|August 30, 2023
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysisHuapeng Lin, Jimmy Che-To Lai, Grace Lai-Hung Wong, et al.JHEP Reports : Innovation in Hepatology|February 24, 2022
Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitisGrace Lai-Hung Wong, Vicki Wing-Ki Hui, Qingxiong Tan, et al.Gut|August 7, 2023
Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trialXinrong Zhang, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2026
Risk stratification of a novel non-invasive fibrosis score in metabolic dysfunction-associated steatotic liver diseaseJohnny T K Cheung, Xinsrong Zhang, Grace Lai-Hung Wong, et al.Journal of Gastroenterology and Hepatology|December 8, 2025
Chronic Hepatitis B Infection: Patient GuidanceLung-Yi Mak, Jimmy Che-To Lai, Ken Liu, et al.Alimentary Pharmacology & Therapeutics|September 19, 2023
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver diseaseJohnny T K Cheung, Xinrong Zhang, Grace Lai-Hung Wong, et al.Alimentary Pharmacology & Therapeutics|February 23, 2023
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide studyXinrong Zhang, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.Pageof 6